The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
It is intended for contrast enhancement in MRI scans
The FDA set a target action date of April 28, 2026, under the Prescription Drug User Fee Act
Additional data will be presented on a once-weekly oral combination of islatravir and ulonivirine (ISL/ULO) for HIV-1 treatment
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06% are bioequivalent to Atrovent Nasal Spray, 0.03% and 0.06%, of Boehringer Ingelheim Pharmaceuticals
Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy
A triple-action Formula for comprehensive respiratory relief
mRNA-1010 demonstrated superior relative vaccine efficacy
Subscribe To Our Newsletter & Stay Updated
